Inogen
INGN
About: Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Employees: 766
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
2.34% more ownership
Funds ownership: 70.82% [Q1] → 73.16% (+2.34%) [Q2]
7% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 45
3% more capital invested
Capital invested by funds: $134M [Q1] → $138M (+$4.36M) [Q2]
2% less funds holding
Funds holding: 127 [Q1] → 124 (-3) [Q2]
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
B. Riley Securities
Anderson Schock
|
$14
|
Buy
Initiated
|
16 Jun 2025 |
Financial journalist opinion
Based on 3 articles about INGN published over the past 30 days